Your browser doesn't support javascript.
loading
Tailoring neoadjuvant chemotherapy for patients with breast cancer who have achieved pathologic complete response.
Li, Xianjun; Liu, Yang; Shan, Ming; Xu, Bingqi; Lu, Yubo; Zhang, Guoqiang.
Affiliation
  • Li X; Department of Breast Surgery, Harbin Medical University Cancer Hospital, China.
  • Liu Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, China.
  • Shan M; Department of Breast Surgery, Harbin Medical University Cancer Hospital, China.
  • Xu B; Department of Breast Surgery, Harbin Medical University Cancer Hospital, China.
  • Lu Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, China.
  • Zhang G; Department of Breast Surgery, Harbin Medical University Cancer Hospital, China.
Transl Cancer Res ; 9(2): 1205-1214, 2020 Feb.
Article in En | MEDLINE | ID: mdl-35117465
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Transl Cancer Res Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Transl Cancer Res Year: 2020 Document type: Article Affiliation country: Country of publication: